{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:07:02Z","timestamp":1788001622777,"version":"build-2784847793"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00259-019-04445-x","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T10:59:40Z","timestamp":1563965980000},"page":"2348-2357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-9516","authenticated-orcid":false,"given":"Jenny","family":"Ceccarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Casteels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawaha","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Crabb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Van de Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Vanhaute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vandenbulcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"4445_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol Elsevier. 2006;5:525\u201335.","journal-title":"Lancet Neurol Elsevier"},{"key":"4445_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease. JAMA. 2014;311:1670.","journal-title":"JAMA."},{"key":"4445_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fneur.2012.00088","volume":"3","author":"J Meireles","year":"2012","unstructured":"Meireles J, Massano J. Cognitive impairment and dementia in Parkinson\u2019s disease: clinical features, diagnosis, and management. Front Neurol. 2012;3:88.","journal-title":"Front Neurol"},{"key":"4445_CR4","doi-asserted-by":"publisher","first-page":"e0152716","DOI":"10.1371\/journal.pone.0152716","volume":"11","author":"Y Tang","year":"2016","unstructured":"Tang Y, Ge J, Liu F, Wu P, Guo S, Liu Z, et al. Cerebral metabolic differences associated with cognitive impairment in Parkinson\u2019s disease. PLoS One. 2016;11:e0152716.","journal-title":"PLoS One"},{"key":"4445_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/S1355617713000295","volume":"19","author":"M Broeders","year":"2013","unstructured":"Broeders M, Velseboer DC, de Bie R, Speelman JD, Muslimovic D, Post B, et al. Cognitive change in newly-diagnosed patients with Parkinson\u2019s disease: a 5-year follow-up study. J Int Neuropsychol Soc. 2013;19:695\u2013708.","journal-title":"J Int Neuropsychol Soc"},{"key":"4445_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1017\/S1355617709090614","volume":"15","author":"D Muslimovi\u0107","year":"2009","unstructured":"Muslimovi\u0107 D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson\u2019s disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009;15:426\u201337.","journal-title":"J Int Neuropsychol Soc"},{"key":"4445_CR7","doi-asserted-by":"crossref","unstructured":"Schapira AHV, Olanow CW, Greenamyre JT, Bezard E. Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: future therapeutic perspectives. Lancet. Elsevier. 2014:545\u201355.","DOI":"10.1016\/S0140-6736(14)61010-2"},{"key":"4445_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nature05506","volume":"445","author":"AC Kreitzer","year":"2007","unstructured":"Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson\u2019s disease models. Nature. 2007;445:643\u20137.","journal-title":"Nature."},{"key":"4445_CR9","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","volume":"18","author":"B Ferrer","year":"2003","unstructured":"Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci. 2003;18:1607\u201314.","journal-title":"Eur J Neurosci"},{"key":"4445_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","volume":"19","author":"M van der Stelt","year":"2005","unstructured":"van der Stelt M, Fox SH, Hill M, Crossman AR, Petrosino S, Di Marzo V, et al. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson\u2019s disease. FASEB J. 2005;19:1140\u20132.","journal-title":"FASEB J"},{"key":"4445_CR11","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","volume":"22","author":"P Gubellini","year":"2002","unstructured":"Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, et al. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci. 2002;22:6900\u20137.","journal-title":"J Neurosci"},{"key":"4445_CR12","doi-asserted-by":"publisher","first-page":"620.e1","DOI":"10.1016\/j.neurobiolaging.2011.02.009","volume":"33","author":"K Van Laere","year":"2012","unstructured":"Van Laere K, Casteels C, Lunskens S, Goffin K, Grachev ID, Bormans G, et al. Regional changes in type 1 cannabinoid receptor availability in Parkinson\u2019s disease in vivo. Neurobiol Aging. 2012;33:620.e1\u20138.","journal-title":"Neurobiol Aging"},{"key":"4445_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.euroneuro.2007.11.003","volume":"18","author":"SAM van Vliet","year":"2008","unstructured":"van Vliet SAM, Vanwersch RAP, Jongsma MJ, Olivier B, Philippens IHCHM. Therapeutic effects of \u03949-THC and modafinil in a marmoset Parkinson model. Eur Neuropsychopharmacol. 2008;18:383\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4445_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/sj.npp.1300407","volume":"29","author":"E Fernandez-Espejo","year":"2004","unstructured":"Fernandez-Espejo E, Caraballo I, Rodriguez de Fonseca F, Ferrer B, El Banoua F, Flores JA, et al. Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function. Neuropsychopharmacology. 2004;29:1134\u201342.","journal-title":"Neuropsychopharmacology"},{"key":"4445_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nbd.2004.10.015","volume":"18","author":"E Fernandez-Espejo","year":"2005","unstructured":"Fernandez-Espejo E, Caraballo I, de Fonseca FR, El Banoua F, Ferrer B, Flores JA, et al. Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism. Neurobiol Dis. 2005;18:591\u2013601.","journal-title":"Neurobiol Dis"},{"key":"4445_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.brainres.2005.12.014","volume":"1073\u20131074","author":"S Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez S, Scorticati C, Garc\u00eda-Arencibia M, de Miguel R, Ramos JA, Fern\u00e1ndez-Ruiz J. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson\u2019s disease. Brain Res. 2006;1073\u20131074:209\u201319.","journal-title":"Brain Res"},{"key":"4445_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnbeh.2011.00057","volume":"5","author":"C Zanettini","year":"2011","unstructured":"Zanettini C, Panlilio LV, Aliczki M, Goldberg SR, Haller J, Yasar S. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci. 2011;5:57.","journal-title":"Front Behav Neurosci"},{"key":"4445_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ddr.20334","volume":"70","author":"SA Varvel","year":"2009","unstructured":"Varvel SA, Wise LE, Lichtman AH. Are CB1 receptor antagonists nootropic or cognitive impairing agents? Drug Dev Res. 2009;70:555\u201365.","journal-title":"Drug Dev Res"},{"key":"4445_CR19","doi-asserted-by":"crossref","unstructured":"Riedel G, Davies SN. Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol. 2005:445\u201377.","DOI":"10.1007\/3-540-26573-2_15"},{"key":"4445_CR20","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1523\/JNEUROSCI.4718-10.2011","volume":"31","author":"H Tan","year":"2011","unstructured":"Tan H, Lauzon NM, Bishop SF, Chi N, Bechard M, Laviolette SR. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci. 2011;31:5300\u201312.","journal-title":"J Neurosci"},{"key":"4445_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nature20127","volume":"539","author":"E Hebert-Chatelain","year":"2016","unstructured":"Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, et al. A cannabinoid link between mitochondria and memory. Nature. 2016;539:555\u20139.","journal-title":"Nature."},{"key":"4445_CR22","first-page":"34","volume":"5","author":"I Akirav","year":"2011","unstructured":"Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci. 2011;5:34.","journal-title":"Front Behav Neurosci"},{"key":"4445_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/sj.npp.1301475","volume":"33","author":"HR Quinn","year":"2008","unstructured":"Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, et al. Adolescent rats find repeated \u03949-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 2008;33:1113\u201326.","journal-title":"Neuropsychopharmacology."},{"key":"4445_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1369-1600.2008.00117.x","volume":"13","author":"M Schneider","year":"2008","unstructured":"Schneider M, Sch\u00f6mig E, Leweke FM. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict Biol. 2008;13:345\u201357.","journal-title":"Addict Biol"},{"key":"4445_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pbb.2014.05.014","volume":"124","author":"A Galanopoulos","year":"2014","unstructured":"Galanopoulos A, Polissidis A, Georgiadou G, Papadopoulou-Daifoti Z, Nomikos GG, Pitsikas N, et al. WIN55,212-2 impairs non-associative recognition and spatial memory in rats via CB1 receptor stimulation. Pharmacol Biochem Behav. 2014;124:58\u201366.","journal-title":"Pharmacol Biochem Behav"},{"key":"4445_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/hipo.22213","volume":"24","author":"BS Basavarajappa","year":"2014","unstructured":"Basavarajappa BS, Subbanna S. CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice\/K2 preparations. Hippocampus. 2014;24:178\u201388.","journal-title":"Hippocampus."},{"key":"4445_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand. 2011;124:250\u201361.","journal-title":"Acta Psychiatr Scand"},{"key":"4445_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/JCP.0000000000000581","volume":"36","author":"MA Katzman","year":"2016","unstructured":"Katzman MA, MFLA. Targeting the endocannabinoid system in psychiatric illness. J Clin Psychopharmacol. 2016;36:691\u2013703.","journal-title":"J Clin Psychopharmacol"},{"key":"4445_CR29","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord. 2010;25:2649\u201353.","journal-title":"Mov Disord"},{"key":"4445_CR30","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.neuroimage.2007.10.053","volume":"39","author":"K Van Laere","year":"2008","unstructured":"Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J, et al. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET. Neuroimage. 2008;39:1533\u201341.","journal-title":"Neuroimage."},{"key":"4445_CR31","doi-asserted-by":"publisher","first-page":"9800","DOI":"10.1073\/pnas.0703472104","volume":"104","author":"HD Burns","year":"2007","unstructured":"Burns HD, Van Laere K, Sanabria-Bohorquez S, Hamill TG, Bormans G, Eng W-S, et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci. 2007;104:9800\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"4445_CR32","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s00259-009-1340-5","volume":"37","author":"SM Sanabria-Boh\u00f3rquez","year":"2010","unstructured":"Sanabria-Boh\u00f3rquez SM, Hamill TG, Goffin K, De Lepeleire I, Bormans G, Burns HD, et al. Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain. Eur J Nucl Med Mol Imaging. 2010;37:920\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4445_CR33","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ. Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain. 2010;133:1755\u201362.","journal-title":"Brain."},{"key":"4445_CR34","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/mds.23823","volume":"26","author":"I Litvan","year":"2011","unstructured":"Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, et al. MDS task force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI. Mov Disord. 2011;26:1814\u201324.","journal-title":"Mov Disord"},{"key":"4445_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13:217\u201331.","journal-title":"Nat Rev Neurol"},{"key":"4445_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","volume":"76","author":"PE Castillo","year":"2012","unstructured":"Castillo PE, Younts TJ, Ch\u00e1vez AE, Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron. 2012;76:70\u201381.","journal-title":"Neuron."},{"key":"4445_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrd2553","volume":"7","author":"V Di Marzo","year":"2008","unstructured":"Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov. 2008;7:438\u201355.","journal-title":"Nat Rev Drug Discov"},{"key":"4445_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of Cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016;73:292.","journal-title":"JAMA Psychiatry"},{"key":"4445_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19124051","volume":"19","author":"S Zou","year":"2018","unstructured":"Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018;19:833.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4445_CR40","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1002\/hbm.24311","volume":"39","author":"L Wu","year":"2018","unstructured":"Wu L, Liu F-T, Ge J-J, Zhao J, Tang Y-L, Yu W-B, et al. Clinical characteristics of cognitive impairment in patients with Parkinson\u2019s disease and its related pattern in 18 F-FDG PET imaging. Hum Brain Mapp. 2018;39(12):4652\u201362.","journal-title":"Hum Brain Mapp"},{"key":"4445_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","volume":"88","author":"MJ Firbank","year":"2017","unstructured":"Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. J Neurol Neurosurg Psychiatry. 2017;88:310\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4445_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","volume":"51","author":"SJ Chung","year":"2018","unstructured":"Chung SJ, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, et al. Effect of striatal dopamine depletion on cognition in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;51:43\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"4445_CR43","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/brain\/awf134","volume":"125","author":"K Ito","year":"2002","unstructured":"Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, et al. Striatal and extrastriatal dysfunction in Parkinson\u2019s disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain. 2002;125:1358\u201365.","journal-title":"Brain."},{"key":"4445_CR44","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, et al. Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol. 2016;73:1334.","journal-title":"JAMA Neurol"},{"key":"4445_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fneur.2018.00138","volume":"9","author":"T Prell","year":"2018","unstructured":"Prell T. Structural and functional brain patterns of non-motor syndromes in Parkinson\u2019s disease. Front Neurol. 2018;9:138.","journal-title":"Front Neurol"},{"key":"4445_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jare.2017.09.004","volume":"8","author":"S Palermo","year":"2017","unstructured":"Palermo S, Morese R, Zibetti M, Dematteis F, Sirgiovanni S, Stanziano M, et al. Impulse control disorder and response-inhibition alterations in Parkinson\u2019s disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature. J Adv Res. 2017;8:713\u20136.","journal-title":"J Adv Res"},{"key":"4445_CR47","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/j.1460-9568.2009.06973.x","volume":"30","author":"D D\u00f6rfel","year":"2009","unstructured":"D\u00f6rfel D, Werner A, Schaefer M, Von Kummer R, Karl A. Distinct brain networks in recognition memory share a defined region in the precuneus. Eur J Neurosci. 2009;30:1947\u201359.","journal-title":"Eur J Neurosci"},{"key":"4445_CR48","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.neuroimage.2003.07.017","volume":"20","author":"BN Lundstrom","year":"2003","unstructured":"Lundstrom BN, Petersson KM, Andersson J, Johansson M, Fransson P, Ingvar M. Isolating the retrieval of imagined pictures during episodic memory: activation of the left precuneus and left prefrontal cortex. Neuroimage. 2003;20:1934\u201343.","journal-title":"Neuroimage."},{"key":"4445_CR49","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neuroimage.2005.05.008","volume":"27","author":"BN Lundstrom","year":"2005","unstructured":"Lundstrom BN, Ingvar M, Petersson KM. The role of precuneus and left inferior frontal cortex during source memory episodic retrieval. Neuroimage. 2005;27:824\u201334.","journal-title":"Neuroimage."},{"key":"4445_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1460-9568.2005.04176.x","volume":"22","author":"N Wenderoth","year":"2005","unstructured":"Wenderoth N, Debaere F, Sunaert S, Swinnen SP. The role of anterior cingulate cortex and precuneus in the coordination of motor behaviour. Eur J Neurosci. 2005;22:235\u201346.","journal-title":"Eur J Neurosci"},{"key":"4445_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/gbb.12097","volume":"13","author":"AE Ruiz-Contreras","year":"2014","unstructured":"Ruiz-Contreras AE, Carrillo-S\u00e1nchez K, Ortega-Mora I, Barrera-Tlapa MA, Rom\u00e1n-L\u00f3pez TV, Rosas-Escobar CB, et al. Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene. Genes Brain Behav. 2014;13:173\u20138.","journal-title":"Genes Brain Behav"},{"key":"4445_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbr.2012.08.031","volume":"236","author":"AE Ruiz-Contreras","year":"2013","unstructured":"Ruiz-Contreras AE, Carrillo-S\u00e1nchez K, G\u00f3mez-L\u00f3pez N, Vadillo-Ortega F, Hern\u00e1ndez-Morales S, Carnevale-Cantoni A, et al. Working memory performance in young adults is associated to the AATn polymorphism of the CNR1 gene. Behav Brain Res. 2013;236:62\u20136.","journal-title":"Behav Brain Res"},{"key":"4445_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.biopsych.2016.07.007","volume":"81","author":"R Saravia","year":"2017","unstructured":"Saravia R, Flores \u00c1, Plaza-Zabala A, Busquets-Garcia A, Pastor A, de la Torre R, et al. CB1 cannabinoid receptors mediate cognitive deficits and structural plasticity changes during nicotine withdrawal. Biol Psychiatry. 2017;81:625\u201334.","journal-title":"Biol Psychiatry"},{"key":"4445_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00213-004-1953-0","volume":"177","author":"PA Arguello","year":"2004","unstructured":"Arguello PA, Jentsch JD. Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat. Psychopharmacology (Berl). 2004;177:141\u201350.","journal-title":"Psychopharmacology (Berl)"},{"key":"4445_CR55","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/npp.2014.213","volume":"40","author":"M Colizzi","year":"2015","unstructured":"Colizzi M, Fazio L, Ferranti L, Porcelli A, Masellis R, Marvulli D, et al. Functional genetic variation of the cannabinoid receptor 1 and Cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology. 2015;40:640\u20139.","journal-title":"Neuropsychopharmacology."},{"key":"4445_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1590\/1980-57642016dn11-020007","volume":"11","author":"ALSB Malak","year":"2017","unstructured":"Malak ALSB, Vasconcellos LF, Pereira JS, Greca DV, Cruz M, Alves HVD, et al. Symptoms of depression in patients with mild cognitive impairment in Parkinson\u2019s disease. Dement Neuropsychol. 2017;11:145\u201353.","journal-title":"Dement Neuropsychol"},{"key":"4445_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00415-015-7929-7","volume":"263","author":"MM Lewis","year":"2016","unstructured":"Lewis MM, Du G, Lee E-Y, Nasralah Z, Sterling NW, Zhang L, et al. The pattern of gray matter atrophy in Parkinson\u2019s disease differs in cortical and subcortical regions. J Neurol. 2016;263:68\u201375.","journal-title":"J Neurol"},{"key":"4445_CR58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jnnp.2006.093849","volume":"78","author":"MK Beyer","year":"2007","unstructured":"Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson\u2019s disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry. 2007;78:254\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04445-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T23:09:50Z","timestamp":1595459390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04445-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4445"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04445-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}